首页> 外文期刊>Expert opinion on therapeutic targets >MRSA: status and prospects for therapy? An evaluation of key papers on the topic of MRSA and antibiotic resistance.
【24h】

MRSA: status and prospects for therapy? An evaluation of key papers on the topic of MRSA and antibiotic resistance.

机译:MRSA:治疗的现状和前景?对有关MRSA和抗生素耐药性主题的关键论文的评估​​。

获取原文
获取原文并翻译 | 示例
           

摘要

Methicillin-resistant Staphylococcus aureus (MRSA) is a serious nosocomial pathogen, and a related community-sourced MRSA is emerging. MRSA has evolved to become the major S. aureus phenotype in the hospital, emerging from just 30 to over 60% of the S. aureus population over the past 15 years. Together with its beta-lactam resistance, MRSA possesses multi-drug resistance genotype, including quinolones, macrolides and sulfonamides. MRSA has now emerged as the predominant nosocomial Gram-positive pathogen, and it has a high rate of mortality. Action must be taken to contain and eradicate MRSA through a combination of infection control and the development of novel anti-MRSA agents and vaccines.
机译:耐甲氧西林金黄色葡萄球菌(MRSA)是一种严重的医院病原体,并且相关的社区来源MRSA也正在兴起。 MRSA已发展成为医院的主要金黄色葡萄球菌表型,在过去15年中仅从30%上升到60%以上。连同其对β-内酰胺的抗性,MRSA具有多重抗药性的基因型,包括喹诺酮类,大环内酯类和磺酰胺类。 MRSA现在已经成为主要的医院革兰氏阳性病原体,并且具有很高的死亡率。必须采取行动,通过结合感染控制和开发新型抗MRSA试剂和疫苗来遏制和根除MRSA。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号